130 related articles for article (PubMed ID: 29996975)
1. The interrelation between FGF23 and glucose metabolism in humans.
Ursem SR; Vervloet MG; Büttler RM; Ackermans MT; Oosterwerff MM; Eekhoff EMV; Lips P; Serlie MJ; la Fleur SE; Heijboer AC
J Diabetes Complications; 2018 Sep; 32(9):845-850. PubMed ID: 29996975
[TBL] [Abstract][Full Text] [Related]
2. Acute hyperinsulinemia is followed by increased serum concentrations of fibroblast growth factor 23 in type 2 diabetes patients.
Winther K; Nybo M; Vind B; Pedersen SM; Højlund K; Rasmussen LM
Scand J Clin Lab Invest; 2012 Apr; 72(2):108-13. PubMed ID: 22133206
[TBL] [Abstract][Full Text] [Related]
3. Prediabetes is Characterized by Higher FGF23 Levels and Higher Prevalence of Vitamin D Deficiency Compared to Normal Glucose Tolerance Subjects.
Gateva A; Assyov Y; Tsakova A; Kamenov Z
Horm Metab Res; 2019 Feb; 51(2):106-111. PubMed ID: 30572348
[TBL] [Abstract][Full Text] [Related]
4. FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results.
Wojcik M; Dolezal-Oltarzewska K; Janus D; Drozdz D; Sztefko K; Starzyk JB
Clin Endocrinol (Oxf); 2012 Oct; 77(4):537-40. PubMed ID: 22103239
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
Fayed A; El Nokeety MM; Heikal AA; Abdulazim DO; Naguib MM; Sharaf El Din UAA;
Ren Fail; 2018 Nov; 40(1):226-230. PubMed ID: 29619868
[TBL] [Abstract][Full Text] [Related]
6. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
[TBL] [Abstract][Full Text] [Related]
7. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status.
Pathak K; Soares MJ; Zhao Y; James AP; Sherriff JL; Newsholme P
Nutrition; 2017 May; 37():37-42. PubMed ID: 28359360
[TBL] [Abstract][Full Text] [Related]
8. Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor.
Streicher C; Zeitz U; Andrukhova O; Rupprecht A; Pohl E; Larsson TE; Windisch W; Lanske B; Erben RG
Endocrinology; 2012 Apr; 153(4):1795-805. PubMed ID: 22294750
[TBL] [Abstract][Full Text] [Related]
9. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
Wolf M; Koch TA; Bregman DB
J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
[TBL] [Abstract][Full Text] [Related]
10. Insulin suppresses the production of fibroblast growth factor 23 (FGF23).
Bär L; Feger M; Fajol A; Klotz LO; Zeng S; Lang F; Hocher B; Föller M
Proc Natl Acad Sci U S A; 2018 May; 115(22):5804-5809. PubMed ID: 29760049
[TBL] [Abstract][Full Text] [Related]
11. Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism.
Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Tripathy D; Jenkinson C; Folli F
Diabetes Care; 2015 Aug; 38(8):1509-17. PubMed ID: 26084344
[TBL] [Abstract][Full Text] [Related]
12. Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23.
Pons-Belda OD; Alonso-Álvarez MA; González-Rodríguez JD; Mantecón-Fernández L; Santos-Rodríguez F
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047636
[TBL] [Abstract][Full Text] [Related]
13. Impact of Phosphorus-Based Food Additives on Bone and Mineral Metabolism.
Gutiérrez OM; Luzuriaga-McPherson A; Lin Y; Gilbert LC; Ha SW; Beck GR
J Clin Endocrinol Metab; 2015 Nov; 100(11):4264-71. PubMed ID: 26323022
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
[TBL] [Abstract][Full Text] [Related]
15. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
16. The association of FGF23 levels in obese adolescents with insulin sensitivity.
Wojcik M; Janus D; Dolezal-Oltarzewska K; Drozdz D; Sztefko K; Starzyk JB
J Pediatr Endocrinol Metab; 2012; 25(7-8):687-90. PubMed ID: 23155694
[TBL] [Abstract][Full Text] [Related]
17. Phosphate control in reducing FGF23 levels in hemodialysis patients.
Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
[TBL] [Abstract][Full Text] [Related]
18. Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets.
Bielohuby M; Sisley S; Sandoval D; Herbach N; Zengin A; Fischereder M; Menhofer D; Stoehr BJ; Stemmer K; Wanke R; Tschöp MH; Seeley RJ; Bidlingmaier M
Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1059-70. PubMed ID: 23982154
[TBL] [Abstract][Full Text] [Related]
19. [Different establishing conditions of hyperinsulinemic-euglycemic clamp technique among different groups].
Yang G; Li CL; Tian H; Cheng SW; Li YJ; Cheng XL; Fang FS
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2410-4. PubMed ID: 23158664
[TBL] [Abstract][Full Text] [Related]
20. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.
Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W
J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
